Short- and Long-term Outcomes of Robotic vs Laparoscopic Right Colon Cancer: a 10-year Single-center Retrospective Study

NCT ID: NCT06454253

Last Updated: 2024-06-12

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 1879 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2014-12-01
• Study Completion Date: 2024-04-30

Brief Summary

The goal of this observational study is to evaluate the short-term outcomes and long-term outcomes of robot-assisted right colon group for cancer compared to laparoscopic-assisted right colon group. This is a large sample study based on ten years of clinical data. The main question it aims to answer is: What are the advantages of da Vinci robot right hemicolectomy compared to laparoscopic right hemicolectomy, and is there a difference in long-term efficacy between the two methods.

Detailed Description

Colorectal cancer (CRC) is highly prevalent worldwide. In China, CRC ranks high among the population of men and women with cancer. The incidence and mortality rates of CRC are rising quickly in developing countries, and it is the fourth most deadly cancer in the world. In particular, the right colon cancer (RCC) is continuously growing in China, and the early symptoms of RCC are not typical. one of the most useful ways for RCC is surgical is a surgical operation. Along with the development of minimally invasive surgery, the use of laparoscopy for colon cancer is widely accepted and has become one symbolic surgical technology. Studies have demonstrated that laparoscopic colonic surgery is related to reduced pain after operation, shorter rehabilitation time, shorter length of hospital stay, reduced the time of ileus after surgery, and reduced surgical site infection.

Nevertheless, laparoscopic surgery also has its shortcoming, including a limited range of motion, slow learning and growth, and physiological tremor cannot be eliminated.The emergence of robots has broken the inherent disadvantage of laparoscopy. It has achieved similar or better results in previous studies. Based on these advantages, robotic surgery has received much attention from the surgeons. With the first robotic surgery in the field of colon cancer was reported in 2002, there are some studies proved the safety and feasibility by using robot,However, most studies with small sample sizes and with cases at a relatively early stage.

Therefore, the purpose of this study is to compare the short-term and long-term outcomes between RARC and LARC in the treatment of right colon cancer in our center.

Conditions

Robotic; Laparoscopic; Colon Cancer; Long-term Outcomes; Short-term Outcomes

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Study Groups

robot-assisted right colon group

Robot assisted radical surgery for right colon cancer

Da Vinci Robot Surgical System

Intervention Type: DEVICE

Performing surgery on right colon cancer patients using the da Vinci robotic surgical system or laparoscopic surgical system

laparoscopic-assisted right colon group

Laparoscopic assisted radical surgery for right colon cancer

Da Vinci Robot Surgical System

Intervention Type: DEVICE

Performing surgery on right colon cancer patients using the da Vinci robotic surgical system or laparoscopic surgical system

Interventions

Da Vinci Robot Surgical System

Performing surgery on right colon cancer patients using the da Vinci robotic surgical system or laparoscopic surgical system

Intervention Type: DEVICE

Other Intervention Names

Laparoscopic surgical system

Eligibility Criteria

Inclusion Criteria

1. The age is more than 18 years old and less than or equal to 85 years old

2. No distant metastasis (including pelvic cavity, peritoneum, liver, lung, brain, bone, distant lymph node metastasis, etc.) is judged by ultrasound, CT, PET-CT, etc

3. Preoperative colonoscopy showing that the tumor was located in the ileocecal region, ascending colon, hepatic flexure, or transverse colon with pathology showing malignancy

4. signed informed consent. -

Exclusion Criteria

1. multiple primary colorectal cancer

2. recurrent right colon cancer

3. preoperative neoadjuvant chemotherapy

4. emergency surgery for intestinal obstruction, bleeding or perforation

5. incomplete data and missing follow-up data. -

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 85 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Taiyuan Li

OTHER

Sponsor Role: lead

Responsible Party

Taiyuan Li

the First Affiliated Hospital of Nanchang University

Responsibility Role: SPONSOR_INVESTIGATOR

Provided Documents

Document Type: Study Protocol

View Document

Other Identifiers

IIT2023015

Identifier Type: -

Identifier Source: org_study_id